Kathmandu, April 16, 2026 — The Sopan Pharmaceuticals IPO opens from today by Sopan Pharmaceuticals Limited. A total of 4,290,000 units of shares worth Rs 429 million have been made available, which is 25% of its issued capital of Rs 1.71 billion.
Out of the total number of units, 429,000 units had already been allotted to Nepalese migrant workers employed abroad, 214,500 units to the mutual fund companies, and 171,600 units for the employees of the firm. In this second issue of shares, the firm is allotting 3,474,900 units to the public at
The minimum number of units that can be applied is 10, and the maximum number is 11,000 units. If the issue is oversubscribed by the due date, then the issue would be closed on April 21, 2026, but if the issue remains unsold, then the issue period ends on April 30, 2026. Applications may be lodged at all banks and financial institutions authorized by C-ASBA or through MeroShare.
The issue has been underwritten by NMB Capital Limited.
The company has been rated ‘B’ by Care Ratings Nepal. This implies a high degree of risk.
Stay tuned to NepseTalk for the latest news.
लोड हुँदैछ...
0 Comments